scPharmaceuticals Inc (SCPH)
NASDAQ
The current SCPH market cap is 167.6M. The company's latest EPS is USD -1.0956 and P/E is -3.06.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.64M | 3.8M | 6.1M | 6.1M | 8.05M |
Operating Income | -13.75M | -14.84M | -15.26M | -15.86M | -14.43M |
Net Income | -14.15M | -15.63M | -13.81M | -14.11M | -17.09M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 13.59M |
Operating Income | -32.91M | -29.93M | -25.82M | -36.16M | -55.4M |
Net Income | -33M | -32.21M | -28.03M | -36.84M | -54.81M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 114.17M | 106.1M | 94.48M | 78.45M | 65.46M |
Total Liabilities | 50.74M | 56.96M | 57.26M | 53.89M | 56.21M |
Total Equity | 63.43M | 49.15M | 37.22M | 24.57M | 9.25M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 77.28M | 109.05M | 79.04M | 124.2M | 94.48M |
Total Liabilities | 25.92M | 26.88M | 22.57M | 51.76M | 57.26M |
Total Equity | 51.37M | 82.17M | 56.47M | 72.43M | 37.22M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -30.64M | -44.09M | -59.24M | -17.7M | -37.93M |
Investing | 16.43M | -6.5M | 19.97M | 29.32M | 29.32M |
Financing | 14.32M | 14.38M | 14.85M | 15k | 298k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -30.44M | -27.69M | -27.15M | -34.58M | -59.24M |
Investing | N/A | -33.46M | 32.13M | -45.86M | 19.97M |
Financing | 13.59M | 60.35M | -2.53M | 77.23M | 14.85M |
Market Cap | 167.6M |
Price to Earnings Ratio | -3.06 |
Price to Sales Ratio | 12.33 |
Price to Cash Ratio | 3.58 |
Price to Book Ratio | 4.5 |
Dividend Yield | - |
Shares Outstanding | 50.03M |
Average Volume (1 week) | 1.33M |
Average Volume (1 Month) | 470.52k |
52 Week Change | -36.43% |
52 Week High | 6.71 |
52 Week Low | 3.075 |
Spread (Intraday) | 0.18 (5.16%) |
Company Name | scPharmaceuticals Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.scpharmaceuticals.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.